Strategies to address low drug solubility in discovery and development

HD Williams, NL Trevaskis, SA Charman… - Pharmacological …, 2013 - Elsevier
Drugs with low water solubility are predisposed to low and variable oral bioavailability and,
therefore, to variability in clinical response. Despite significant efforts to “design in” …

Cyclodextrins in drug delivery systems and their effects on biological barriers

Á Haimhoffer, Á Rusznyák, K Réti-Nagy… - Scientia …, 2019 - mdpi.com
Cyclodextrins are widely used excipients, composed of glucopyranose units with a cyclic
structure. One of their most important properties, is that their inner cavity is hydrophobic …

Multidrug resistance: Physiological principles and nanomedical solutions

S Kunjachan, B Rychlik, G Storm, F Kiessling… - Advanced drug delivery …, 2013 - Elsevier
Multidrug resistance (MDR) is a pathophysiological phenomenon employed by cancer cells
which limits the prolonged and effective use of chemotherapeutic agents. MDR is primarily …

Evaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extraction

T Kiss, F Fenyvesi, I Bácskay, J Váradi… - European journal of …, 2010 - Elsevier
Several β-cyclodextrin (β-CD) derivatives have been synthesized recently to improve the
physicochemical properties and inclusion capacities of the parent molecule, however, there …

Cyclodextrins-modified metallic nanoparticles for effective cancer therapy

S Gandhi, P Shende - Journal of Controlled Release, 2021 - Elsevier
Cancer, a disease of unknown origin is the second most common reason of death worldwide
after heart attacks and therefore is a major threat to human beings. Currently, chemotherapy …

Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake …

X Han, Z Li, J Sun, C Luo, L Li, Y Liu, Y Du… - Journal of Controlled …, 2015 - Elsevier
Stealth active targeting nanoparticles (NPs) usually include two types of ligand sites: ligand
anchored on distal ends of the polyethylene glycol (PEG) and ligand buried under pegylated …

Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement

FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - Springer
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …

Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly (anhydride) nanoparticles

M Agüeros, V Zabaleta, S Espuelas… - Journal of Controlled …, 2010 - Elsevier
The aim of this work was to study the oral bioavailability in rats of paclitaxel (PTX) when
encapsulated as a complex with cyclodextrins in poly (anhydride) nanoparticles (NP). For …

Combined hydroxypropyl-β-cyclodextrin and poly (anhydride) nanoparticles improve the oral permeability of paclitaxel

M Agüeros, L Ruiz-Gatón, C Vauthier… - European Journal of …, 2009 - Elsevier
The aim of this work was to study the effect of the combination between 2-hydroxypropyl-β-
cyclodextrin (HPCD) and bioadhesive nanoparticles on the encapsulation and intestinal …

Cyclodextrins, blood–brain barrier, and treatment of neurological diseases

M Vecsernyés, F Fenyvesi, I Bácskay, MA Deli… - Archives of medical …, 2014 - Elsevier
Biological barriers are the main defense systems of the homeostasis of the organism and
protected organs. The blood–brain barrier (BBB), formed by the endothelial cells of brain …